nejm semaglutide ckd 🚨New Trial Results🚨 improves chronic kidney disease outcomes by 24% in pts with type 2 diabetes and CKD, in @NEJM today. ⬇️29% cardiovascular death ⬇️18% cardiovascular events ⬇️20% all-cause mortality Slower Incidence of Chronic Kidney Disease

The risk is managed by close glucose monitoring and clinician-guided insulin changes

In the case of Sermorelin-Ipamorelin-CJC1295, the choice is an easy one

or BMI 27 or higher with prediabetes, prior heart attack, prior stroke, or symptomatic peripheral artery disease

Niacinamide one of the four ingredients in the Vitality NAD+ Booster plays a specific role in that synthesis pathway

Gently cleanses without stripping the skin

[29] Forty minutes after the researchers treated skin samples with high levels of DHA they found that more than 180 percent additional free radicals formed during sun exposure compared with untreated skin